Jump to content

Search results

  • |title=Palliative Care for Mesothelioma: Symptom Management, Early Integration & Support ...m management (dyspnea, pain, fatigue), psychological support, advance care planning, palliative procedures, caregiver resources, cost benefits, and current ASC ...
    71 KB (9,109 words) - 09:57, 6 April 2026
  • ...anning has never been more important for ensuring patients receive optimal care while families pursue full compensation for [[Asbestos Exposure|asbestos ex | style="padding:15px; " | '''✅ Surgical Advance:''' Some experienced centers report 0% mortality for P/D procedures. The sh ...
    33 KB (3,904 words) - 20:57, 20 February 2026
  • ...nually—the highest volume in the nation.<ref>[https://www.mskcc.org/cancer-care/types/mesothelioma Mesothelioma at Memorial Sloan Kettering], Memorial Sloa * '''U.S. News Ranking:''' Consistently ranked #2 nationally for cancer care ...
    29 KB (3,631 words) - 20:56, 20 February 2026
  • ...padding:10px; border-bottom:1px solid #dee2e6; color:#000000;" | #4 Cancer Care (2025-26) ...Mayo Clinic</ref> U.S. News & World Report ranks Mayo Clinic #4 in cancer care for 2025-26, while the institution overall ranks #3 nationally. ...
    29 KB (3,526 words) - 20:56, 20 February 2026
  • ...n and correlate with shorter survival, informing gender-specific treatment planning Under Dr. Bueno's direction, the IMP continues to advance personalized medicine approaches that match individual patients with their ...
    24 KB (3,099 words) - 04:00, 9 March 2026
  • | style="padding:15px; " | '''✓ Treatment Advance:''' HIPEC (heated intraperitoneal chemotherapy) has dramatically improved p * Treatment planning ...
    25 KB (3,138 words) - 20:56, 20 February 2026
  • ...QLEX''' following in January 2026. VT3989, the first TEAD inhibitor, will advance to '''Phase III registration trials''' in the first half of 2026, represent ...ficant 2.8-month improvement that established a new first-line standard of care ...
    39 KB (4,791 words) - 23:07, 10 March 2026
  • ...These differences have important implications for diagnosis and treatment planning. ...obstructive disease. This remains the most common misdiagnosis in primary care settings. ...
    40 KB (5,072 words) - 20:56, 20 February 2026
  • ...y differ, and why the distinction matters for patients seeking both proper care and maximum financial recovery. With over '''$30 billion available''' in as * '''Palliative care is NOT giving up''' — Early integration improves survival; recommended from ...
    91 KB (11,214 words) - 15:25, 24 February 2026
  • ...oid patients. Accurate cell type identification is essential for treatment planning — always request immunohistochemistry testing on your biopsy sample. ...order-bottom:1px solid #dee2e6;" | Chemotherapy, immunotherapy, palliative care, clinical trials ...
    220 KB (28,527 words) - 01:11, 6 April 2026